Latest HELP Therapeutics News & Updates

See the latest news and media coverage for HELP Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

HELP Therapeutics

Regenerative medicine company developing cell therapies

helptherapeutics.com

Founded year: 2016
Company type: Private company
Number of employees: 51–200
Industry: Pharmaceuticals

Last updated October 20

Latest news about HELP Therapeutics

In short: HELP Therapeutics advanced HiCM-188 into Phase III after Nature Medicine published positive trial results.

Company announcements

October 20 HELP Therapeutics

HELP Therapeutics advances HMM-910 to Phase II

Trial led by Nanjing Drum Tower Hospital explores UC-MSCs for postmenopausal women with high osteoporosis fracture risk.

August 26 HELP Therapeutics

HELP Therapeutics advances HiCM-188 clinical trials to the U.S

Collaborating with Texas Heart Institute on a Phase I/IIa study evaluating safety and tolerability. Enrollment is anticipated for late 2026 following recent Nature Medicine publication.

August 19 HELP Therapeutics

HELP Therapeutics announces HEAL-CHF trial results

The publication in Nature Medicine shows encouraging safety and efficacy data for iPSC-based cardiac therapy in heart failure patients.

October 15, 2025 HELP Therapeutics

HELP Therapeutics' new stem cell drug receives clinical approval

Its injectable human umbilical cord mesenchymal stem cells HiCM388 have been approved for use in the treatment following reperfusion therapy for acute myocardial infarction.

Media coverage

August 17 Crew Daily

Crwe World | HELP Therapeutics Announces Nature Medicine Has Published HiCM-188 Clinical Trial Data for Advanced Ischemic Heart Failure

NANJING, CHINA, August 20, 2026 - (ACN Newswire) - Aug 19, HELP Therapeutics today announced the Nature Medicine publication of 12-month results from the H...

September 13, 2025 KXAN

HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure in Mainland China

NANJING, China, June 16, 2025 /PRNewswire/ -- HELP Therapeutics, a global leader in regenerative medicine, and China Resources Sanjiu Pharmaceutical Company, one of China's largest...

June 16, 2025 PR Newswire

HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure in Mainland China

/PRNewswire/ -- HELP Therapeutics, a global leader in regenerative medicine, and China Resources Sanjiu Pharmaceutical Company, one of China's largest...

October 22, 2024 BioSpace

HELP Therapeutics announces FDA clearance of IND application for universal iPSC-derived HiCM-188 cell therapy for the treatment of end-stage heart failure - BioSpace

HiCM-188, a leading pipeline program of HELP Therapeutics, consists of highly purified allogeneic cardiomyocytes (cardiac muscle cells) reprogrammed from human induced pluripotent stem (iPS) cells...

Never miss news about HELP Therapeutics

Track HELP Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

HELP Therapeutics competitors & trending companies

Browse news for competitors to HELP Therapeutics and other trending companies.